Overview
LFWD market data
Price History
LFWD price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$17.16 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.48 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -154.2% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $4.14 – $10.56 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $21.2M · P/B 1.25 · P/S 1.44.
Company News
Lifeward Launches Six-Mointh Pilot Program With Ottobock Care To Enable Greater Patient Access To Its ReWalk 7 Personal ExoskeletonBenzinga · Aug 5, 2026, 12:04 PM
8-K filing — Lifeward Ltd. (LFWD)SEC EDGAR · Jul 7, 2026, 8:30 PM
Lifeward Appoints Dr. Keith D. Rose as Chief Medical Officer to Support Expansion of Neurorehabilitation Portfolio and Advance Biomed PlatformGlobenewswire Inc · May 19, 2026, 12:15 PM
Lifeward Q1 2026 Earnings Call TranscriptBenzinga · May 15, 2026, 1:15 PM
Lifeward Q1 Adj. EPS $(3.13) Misses $(1.25) Estimate, Sales $3.923M Miss $5.775M EstimateBenzinga · May 15, 2026, 12:30 PM
Earnings Scheduled For May 15, 2026Benzinga · May 15, 2026, 11:15 AM